By
Dr. Hatim El Karni
,
Dr. Bezzaz Aicha
,
Dr. El Ghanmi Jihad
,
Dr. Koutani Abdelatif
,
Dr. Bayahia Rabia
,
Dr. Hachimi Mohamed
Corresponding Author Dr. Hatim El Karni
Urology CHU Rabat Morocco, - Morocco
Submitting Author Dr. Hatim El Karni
Other Authors
Dr. Bezzaz Aicha
Nephrology, - Morocco
Dr. El Ghanmi Jihad
Urology, - Morocco
Dr. Koutani Abdelatif
Urology, - Morocco
Dr. Bayahia Rabia
Nephrology, - Morocco
Dr. Hachimi Mohamed
Urology, - Morocco
Urothelium, Bladder Tumor, Tumor of the upper collecting system
El Karni H, Aicha B, Jihad E, Abdelatif K, Rabia B, Mohamed H. A Very Rare Indication in Urology: Ablation of all the Urinary Organs: About A Case. WebmedCentral UROLOGY 2011;2(8):WMC002102
doi:
10.9754/journal.wmc.2011.002102
No
Introduction
Urothelial neoplasm may occur at different levels of the urinary collecting system in a synchronous or metachronous way which may explain their multicentric characteristics.
The real mechanism staying behind this multifocality isn?t yet established.
Tumors of the upper urinary collecting system are the less common and account for only 5% of urothelial neoplasm.
The therapeutic attitude for solitary kidney; bilateral tumors or kidney failure may be conservative; however in case of advanced stage disease a radical? treatment should be established.
We do report a case study of a patient having bilateral urinary collecting system tumor , associated with bladder and urethral tumor.
Case Report(s)
23 years old men with no past medical history or toxic habits presented during 01 month a terminal hematuria.
Clinical examination was normal
Blood tests showed a haemoglobin level of 11g/dl and a normal kidney function.
Radiological investigations using abdominal ultrasonography showed the presence of a 20mm bladder lesion.
After an initial cystoscopy, an endoscopic resection of this lesion was made; the pathological staging was in favour of an urothelial carcinoma stage pTaG2.
Thereafter repeated cystoscopic evaluation each 3 to 6 months was held.
9 months later, the patient had his first recurrence, so an endoscopic resection of a 20mm bladder lesion was enrolled; the histological staging was a pTaG2.
3 months later a second recurrence occurred; cystoscopy showed multiple and diffuses small bladder lesions associated with with urethral localisations.
After a complete endoscopic resection of this lesions the histological staging was established as pT1G1; then 01 month later the patient received 4 instillations of BCG therapy.
Unfortunately the patient didn?t t stick to the regular cystoscopic control; hence 1 year later he consulted to the emergency department in a severe hematuria.
Blood tests were as follow: hg level = 4g/dl
Creatinine= 200mg/l
Urea=3.5g/l
Abdominal sonography demonstrated the presence of multiple bladder lesion and upper urinary system dilation.
There for the patient received initially 1 session of haemodialysis along blood transfusion.
The patient was admitted to the operative room in order to treat this acute kidney failure by putting ureteral catheter; however? this technique failed so we decided to do kidney drainage via bilateral nephrostomy.
Creatinine level decreased to a level of 40mg/l with a calculated clearance of 20ml/min.
There after a scan without injection was performed that made in evidence , the presence of bladder tumor associated with bilateral kidney pelvis tumor. (illustration 1,2,3)
Hence in front of such results we voted for the ablation of all urinary system; which means bilateral nephroureterectomy along cystectomy and urethrectomy. (illustration 4,5)
The post operative follow up was normal and the disease evolution was with out any particularity .
The pathological staging of kidney pelvis tumor was a urothelial carcinoma of low grade stage pT1; for the right ureter it was a pTa ; bladder ( pT1) and penien urethra (pT1).
Now ; we are at 9 months distance from the operative act and both scans done at the 3rd and the 9th month showed no signs of local or metastatic recurrence.
Reference
1. J. Irani, S. Bernardini, J.L. Bonnal, B. et AL .Tumeurs uroth?liales, Prog Urol 17 (2007), pp. 1065?1098.
2. M.C. Hall, S. Womack, A.I. Sagalowsky, et AL. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients, Urology 52 (1998), pp. 594?601.
3. A.P. Grollman, S. Shibutani, M. Moriya, et AL. Aristolochic acid and the etiology of endemic (Balkan) nephropathy, Proc Natl Acad Sci U S A 104 (2007), pp. 12129?12134.
4. L.J. Wang, Y.C. Wong, C.C. Huang, et AL. Chen, Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria, J Urol 183 (2010), pp. 48?55.
5. S. Daneshmand, M.L. Quek and J.L. Huffman, Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience, Cancer 98 (2003), pp. 55?60.
Source(s) of Funding
none
Competing Interests
none
Disclaimer
This article has been downloaded from WebmedCentral. With our unique author driven post publication peer
review, contents posted on this web portal do not undergo any prepublication peer or editorial review. It is
completely the responsibility of the authors to ensure not only scientific and ethical standards of the manuscript
but also its grammatical accuracy. Authors must ensure that they obtain all the necessary permissions before
submitting any information that requires obtaining a consent or approval from a third party. Authors should also
ensure not to submit any information which they do not have the copyright of or of which they have transferred
the copyrights to a third party.
Contents on WebmedCentral are purely for biomedical researchers and scientists. They are not meant to cater to
the needs of an individual patient. The web portal or any content(s) therein is neither designed to support, nor
replace, the relationship that exists between a patient/site visitor and his/her physician. Your use of the
WebmedCentral site and its contents is entirely at your own risk. We do not take any responsibility for any harm
that you may suffer or inflict on a third person by following the contents of this website.